1. Home
  2. CADL vs BVS Comparison

CADL vs BVS Comparison

Compare CADL & BVS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Candel Therapeutics Inc.

CADL

Candel Therapeutics Inc.

HOLD

Current Price

$9.46

Market Cap

694.6M

Sector

Health Care

ML Signal

HOLD

Logo Bioventus Inc.

BVS

Bioventus Inc.

HOLD

Current Price

$11.85

Market Cap

783.2M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
CADL
BVS
Founded
1999
2011
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Biotechnology: Electromedical & Electrotherapeutic Apparatus
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
694.6M
783.2M
IPO Year
2021
2016

Fundamental Metrics

Financial Performance
Metric
CADL
BVS
Price
$9.46
$11.85
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
7
3
Target Price
$19.00
$14.00
AVG Volume (30 Days)
1.4M
666.3K
Earning Date
05-14-2026
05-06-2026
Dividend Yield
N/A
N/A
EPS Growth
58.62
163.46
EPS
N/A
0.04
Revenue
$125,000.00
$568,087,000.00
Revenue This Year
N/A
$7.52
Revenue Next Year
N/A
$7.06
P/E Ratio
N/A
$295.00
Revenue Growth
N/A
N/A
52 Week Low
$4.35
$5.81
52 Week High
$11.36
$12.53

Technical Indicators

Market Signals
Indicator
CADL
BVS
Relative Strength Index (RSI) 50.20 58.18
Support Level $9.19 $8.04
Resistance Level $11.36 $12.53
Average True Range (ATR) 0.58 0.54
MACD -0.07 -0.07
Stochastic Oscillator 24.29 41.30

Price Performance

Historical Comparison
CADL
BVS

About CADL Candel Therapeutics Inc.

Candel Therapeutics Inc is a clinical stage biopharmaceutical company focused on developing off-the-shelf viral immunotherapies that elicit an individualized, systemic anti-tumor immune response to help patients fight cancer. The immune cells induced by these viral immunotherapies are believed to target patients' specific tumor antigens, potentially improving responses in immunologically hot tumors while at the same time infiltrating the tumor microenvironment, transforming non-inflamed cold tumors with limited immune response into hot tumors. The company has established two clinical off-the-shelf viral immunotherapy platforms based on novel, genetically modified adenovirus and herpes simplex virus (HSV) constructs, respectively.

About BVS Bioventus Inc.

Bioventus Inc is a medical device company focused on developing and commercializing products to relieve pain and address musculoskeletal conditions. The company operates through two reporting segments, U.S. and International, and its product portfolio is organized into three main business areas: Pain Treatments, Surgical Solutions, and Restorative Therapies, offering products such as hyaluronic acid injections for osteoarthritis, peripheral nerve stimulation devices, bone graft substitutes, and ultrasound-based fracture healing therapies.

Share on Social Networks: